Non-ischaemic mitral valve suture annuloplasty: late follow-up results

Rimantas Benetis1, Paulius Orda2, Jolanta Justina Vaškelytė3

  • 1Cardiology Department, Lithuanian University of Health Sciences, Kaunas, Lithuania Cardiac Surgery Department, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Perfusion
|April 27, 2016
PubMed
Abstract

Insights

Posterior mitral valve double-suture annuloplasty effectively treats degenerative mitral valve disease for up to 9 years. This technique maintains a competent mitral valve (MV) and promotes positive left ventricular (LV) remodeling.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Repair
  • Mitral Valve Disease

Background:

  • Degenerative mitral valve insufficiency requires effective surgical repair techniques.
  • Long-term outcomes of posterior mitral valve annulus double-suture annuloplasty are not well-established.

Purpose of the Study:

  • To evaluate the late outcomes of posterior mitral valve (MV) annulus double-suture annuloplasty for degenerative (non-ischaemic) MV insufficiency.

Main Methods:

  • 138 patients underwent posterior MV double-suture annuloplasty between 2005-2011.
  • Study assessed operative mortality, reoperation rates, and echocardiographic parameters.
  • Follow-up periods ranged from 2 to 9 years.

Main Results:

  • In-hospital mortality was 1.45%.
  • Late follow-up showed no or mild regurgitation (grade ⩽II(o)) in 96.6% of patients.
  • Significant reduction in MV annulus diameter and left ventricular end-diastolic diameter (LVEDD) was observed, with preserved left ventricular ejection fraction (LVEF).

Conclusions:

  • Posterior mitral valve double-suture annuloplasty is an effective treatment for degenerative mitral valve disease up to 9 years.
  • The technique provides stable long-term reduction of the posterior MV annulus diameter.
  • It results in a competent MV and positive left ventricular (LV) remodeling.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
424
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
396
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
516
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
873
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.0K